Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Megakaryocyte-associated tyrosine kinase pseudogene (ENSG00000267148) is a processed pseudogene related to the protein-coding gene MATK, which encodes the functional megakaryocyte-associated tyrosine kinase[5][1]. Like other pseudogenes, it shares high sequence similarity with its parent gene but does not encode a functional protein due to disruptions such as premature stop codons or frameshift mutations[3]. Pseudogenes can be transcribed as non-coding RNAs, which may play regulatory roles in gene expression, typically functioning at low abundance and with tissue specificity, but their exact biological impact is largely uncharacterized[3]. There is no evidence that this pseudogene functions as a therapeutic target or encodes a receptor, enzyme, transporter, or similar molecule, and there are no known drugs that act on it[5][3]. The protein-coding parental gene ("MATK") belongs to the tyrosine kinase family, but the pseudogene itself is not an active kinase and should not be confused with its functional counterpart[5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Megakaryocyte-associated tyrosine kinase pseudogene.